TASLY PHARMACEUTICA GROUP financial statements, including revenue, expenses, profit, and loss
The total revenue of 600535 for the last quarter is 2.02 B CNY, and it's 2.13% lower compared to the previous quarter. The net income of Q1 24 is 295.21 M CNY.